Tech Company Financing Transactions
Molecular Templates Funding Round
On 10/8/2013, Molecular Templates raised $8.5 million in Series C financing from Excel Venture Management and Sante Ventures.
Transaction Overview
Company Name
Announced On
10/8/2013
Transaction Type
Venture Equity
Amount
$8,500,000
Round
Series C
Investors
Excel Venture Management (Lead Investor) (Caleb Winder)
Sante Ventures (Kevin Lalande)
Proceeds Purpose
This round of financing will allow us to develop our technology around antibody-drug conjugates, siRNA delivery, and enzyme replacement therapy while continuing to advance our lead compound, MT-3724.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
9301 Amberglen Blvd. 100
Austin, TX 78729
USA
Austin, TX 78729
USA
Phone
Website
Email Address
Not Recorded
Overview
Molecular Templates Inc. is creating an entirely new generation of potent anti-cancer agents based on proprietary applied proteomics technologies.The novel therapeutic agents in development by MTI are aimed particularly at melanoma, prostate and other metastatic cancers.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Eric Poma
Chief Financial Officer
Adam Cutler
Chief Medical Officer
Roger Waltzman
Chief Operating Officer
Jason Kim
Browse more venture capital transactions:
Prev: 10/8/2013: Retrophin venture capital transaction
Next: 10/8/2013: PINC Solutions venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs